04:11 PM EDT, 06/13/2024 (MT Newswires) -- Edward Morrow Atkinson III, Executive Vice President, Chief Technical Operations Officer, on June 11, 2024, sold 7,288 shares in Vertex Pharmaceuticals ( VRTX ) for $3,483,664. Following the Form 4 filing with the SEC, Atkinson has control over a total of 15,972 shares of the company, with 15,972 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532024000174/xslF345X03/wk-form4_1718309345.xml